Cited by 1,037Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.

Tau pathology in Alzheimer disease and other tauopathies

Open access

Iqbal, Khalid, del C. Alonso, Alejandra, Chen, She, Chohan, M. Omar, El-Akkad, Ezzat, Gong, Cheng-Xin, Khatoon, Sabiha, Li, Bin, Liu, Fei, Rahman, Abdur, Tanimukai, Hitoshi, Grundke-Iqbal, Inge·2005·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

DOI 10.1016/j.bbadis.2004.09.008

Open this paper in CoChat — free account

Abstract

Just as neuronal activity is essential to normal brain function, microtubule-associated protein tau appears to be critical to normal neuronal activity in the mammalian brain, especially in the evolutionary most advanced species, the homo sapiens. While the loss of functional tau can be compensated by the other two neuronal microtubule-associated proteins, MAP1A/MAP1B and MAP2, it is the dysfunctional, i.e., the toxic tau, which forces an affected neuron in a long and losing battle resulting in a slow but progressive retrograde neurodegeneration. It is this pathology which is characteristic of Alzheimer disease (AD) and other tauopathies. To date, the most established and the most compelling cause of dysfunctional tau in AD and other tauopathies is the abnormal hyperphosphorylation of tau. The abnormal hyperphosphorylation not only results in the loss of tau function of promoting assembly and stabilizing microtubules but also in a gain of a toxic function whereby the pathological tau sequesters normal tau, MAP1A/MAP1B and MAP2, and causes inhibition and disruption of microtubules. This toxic gain of function of the pathological tau appears to be solely due to its abnormal hyperphosphorylation because dephosphorylation converts it functionally into a normal-like state. The affected neurons battle the toxic tau both by continually synthesizing new normal tau and as well as by packaging the abnormally hyperphosphorylated tau into inert polymers, i.e., neurofibrillary tangles of paired helical filaments, twisted ribbons and straight filaments. Slowly but progressively, the affected neurons undergo a retrograde degeneration. The hyperphosphorylation of tau results both from an imbalance between the activities of tau kinases and tau phosphatases and as well as changes in tau's conformation which affect its interaction with these enzymes. A decrease in the activity of protein phosphatase-2A (PP-2A) in AD brain and certain missense mutations seen in frontotemporal dementia promotes the abnormal hyperphosphorylation of tau. Inhibition of this tau abnormality is one of the most promising therapeutic approaches to AD and other tauopathies.

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2004.09.008

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
Cohen, P. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002321 · Cited by 2,543
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780

Show all 154 references

Sorted by citations

Items 401–500 of 999

Alkaloids as Potential Multi-Target Drugs to Treat Alzheimer's Disease
Lima, J. A., & Hamerski, L. (2018) · Studies in natural products chemistry · doi:10.1016/b978-0-444-64183-0.00008-7 · Cited by 34
Genetic Variants and Oxidative Stress in Alzheimer’s Disease
Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 34
Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3ζ protein
Sadik, G., Tanaka, T., Kato, K., Yanagi, K., Kudo, T., & Takeda, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.107 · Cited by 33
Altered Regulation of Akt Signaling with Murine Cerebral Malaria, Effects on Long-Term Neuro-Cognitive Function, Restoration with Lithium Treatment
Dai, M., Freeman, B. D., Shikani, H. J., Bruno, F., Collado, J., Macias, R., Reznik, S. E., Davies, P. J., Spray, D. C., Tanowitz, H. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044117 · Cited by 32
Aggregation Kinetics and Filament Structure of a Tau Fragment Are Influenced by the Sulfation Pattern of the Cofactor Heparin
Townsend, D. J., Fullwood, N. J., Yates, E. A., & Middleton, D. A. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00443 · Cited by 32
Viral Infections, Are They a Trigger and Risk Factor of Alzheimer’s Disease?
Rippee‐Brooks, M. D., Wu, W., Dong, J., Pappolla, M. A., Fang, X., & Bao, X. (2024) · Pathogens · doi:10.3390/pathogens13030240 · Cited by 31
R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease
Carreras, I., McKee, A. C., Choi, J., Aytan, N., Kowall, N. W., Jenkins, B. G., & Dedeoglu, A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.025 · Cited by 35
Free-floating adult human brain-derived slice cultures as a model to study the neuronal impact of Alzheimer’s disease-associated Aβ oligomers
Mendes, N. D., Fernandes, A., de Almeida, G. M., Santos, L. E., Sellés, M. C., Silva, N. M. L. E., Machado, C. D. M., Horta‐Júnior, J. D. A. C., Louzada, P. R., Felice, F. G. D., et al. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.05.021 · Cited by 35
14-3-3ζ Facilitates GSK3β-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3β on Ser9
Li, T., & Paudel, H. K. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.073 · Cited by 32
Caffeine for Prevention of Alzheimer’s Disease: Is the A2A Adenosine Receptor Its Target?
Merighi, S., Travagli, A., Nigro, M., Pasquini, S., Cappello, M., Contri, C., Varani, K., Vincenzi, F., Borea, P. A., & Gessi, S. (2023) · Biomolecules · doi:10.3390/biom13060967 · Cited by 37
Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach
Castro-Álvarez, J. F., Uribe‐Arias, A., MejÃa-Raigosa, D., & Cardona‐Gómez, G. P. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00232 · Cited by 34
Emerging pathways in genetic Parkinson’s disease: tangles, Lewy bodies and LRRK2
Devine, M. J., & Lewis, P. A. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06707.x · Cited by 30
Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease
Tzekaki, E. E., Papaspyropoulos, A., Tsolaki, M., Lazarou, E., Kozori, M., & Pantazaki, Α. A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111178 · Cited by 31
Alzheimer’s Disease and Herbal Combination Therapy: A Comprehensive Review
Pradeep, S., Jain, A. S., Dharmashekara, C., Prasad, S. K., Kollur, S. P., Syed, A., & Shivamallu, C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200228 · Cited by 30
Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32
Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies
Olešová, D., Dobešová, D., Majerová, P., Brumarová, R., Kvasnička, A., Kouřil, Š., Stevens, E., Hanes, J., Fialová, Ľ., Michalicová, A., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03060-4 · Cited by 33
GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression
Rekha, A., Afzal, M., Babu, M. A., Menon, S. V., Nathiya, D., Supriya, S., Mishra, S. B., Gupta, S., Goyal, K., Rana, M., et al. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.104005 · Cited by 34
Shared Molecular Mechanisms among Alzheimer’s Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review
Falsetti, L., Viticchi, G., Zaccone, V., Guerrieri, E., Moroncini, G., Luzzi, S., & Silvestrini, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020439 · Cited by 30
PPP2R2B CAG repeat length in the Han Chinese in Taiwan: Association analyses in neurological and psychiatric disorders and potential functional implications
Chen, C., Hou, Y., Liu, J., Wu, Y., Lin, C., Fung, H., Hsu, W., Hsu, Y., Lee, S., Hsieh-Li, H.-M., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30785 · Cited by 30
Drosophila lacking the Cdk5 activator, p35, display defective axon guidance, age-dependent behavioral deficits and reduced lifespan
Connell‐Crowley, L., Vo, D. J., Luke, L., & Giniger, E. (2007) · Mechanisms of Development · doi:10.1016/j.mod.2007.02.002 · Cited by 30
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [ 18 F]MK6240 Tau PET in Target Regions
Tissot, C., Servaes, S., Lussier, F. Z., Ferrari‐Souza, J. P., Therriault, J., Ferreira, P. C. L., Bezgin, G., Bellaver, B., Leffa, D. T., Mathotaarachchi, S. S., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264434 · Cited by 30
Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology
Bashir, S., Aiman, A., Shahid, M., Chaudhary, A. A., Sami, N., Basir, S. F., Hassan, M. I., & Islam, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102276 · Cited by 31
Flavonoids and Alzheimer’s disease: reviewing the evidence for neuroprotective potential
Amin, M. A., Dehbia, Z., Nafady, M. H., Zehravi, M., Kumar, K. P., Haque, M. A., Baig, M. S., Farhana, A., Khan, S. L., Afroz, T., et al. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04922-w · Cited by 29
Relationship Between Thyroid Hormone Levels and the Pathology of Alzheimer's Disease in Euthyroid Subjects
Choi, B. W., Kim, S., Kang, S., Won, K. S., Yi, H., & Kim, H. W. (2020) · Thyroid · doi:10.1089/thy.2019.0727 · Cited by 29
Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
Duquette, A., Pernègre, C., Carpentier, A. V., & Leclerc, N. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.607680 · Cited by 38
A Two Decade Contribution of Molecular Cell Biology to the Centennial of Alzheimer's Disease: Are We Progressing Toward Therapy?
Dillen, K., & Annaert, W. G. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)54005-7 · Cited by 29
Diffusion tensor imaging reveals whole-brain microstructural changes in the P301L mouse model of tauopathy.
Massalimova, A., Ni, R., Nitsch, R. M., Reisert, M., von Elverfeldt, D., & Klohs, J. (2020) · Neurodegenerative Diseases · doi:10.1159/000515754 · Cited by 28
Ginger, a Possible Candidate for the Treatment of Dementias?
Schepici, G., Contestabile, V., Valeri, A., & Mazzon, E. (2021) · Molecules · doi:10.3390/molecules26185700 · Cited by 29
Animal models of Alzheimer’s disease: preclinical insights and challenges
Xu, Q., Yang, W., Zhong, M., Lin, Z., Gray, N. E., & Xian, Y. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0001 · Cited by 30
Novel Sites of Neuroprotective Action of Dimebon (Latrepirdine)
Ustyugov, A. A., Shevtsova, E. F., & Бачурин, С. О. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9249-4 · Cited by 28
Splicing factor SC35 promotes tau expression through stabilization of its mRNA
Qian, W., Iqbal, K., Grundke, I., Gong, C., & Liu, F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.017 · Cited by 28
Modulation of hippocampal calcium signalling and plasticity by serine/threonine protein phosphatases
Koss, D. J., Hindley, K. P., Riedel, G., & Platt, B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04579.x · Cited by 28
Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy
Buccarello, L., Grignaschi, G., Castaldo, A., Giancamillo, A. D., Domeneghini, C., Melcangi, R. C., & Borsello, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161087 · Cited by 30
Biomarkers of Mild Cognitive Impairment and Alzheimer’s Disease
Tang, B. L., & Kumar, R. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n5p406 · Cited by 29
Pharmacological investigations on efficacy of Phlorizin a sodium-glucose co-transporter (SGLT) inhibitor in mouse model of intracerebroventricular streptozotocin induced dementia of AD type
Rani, R., Kumar, A., Jaggi, A. S., & Singh, N. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0330 · Cited by 27
Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs
Medrano-Jiménez, E., Meza‐Sosa, K. F., Aragon, J. A. U., Secundino, I., Pedraza-Alva, G., & Pérez-Martínez, L. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr1021-531r · Cited by 28
Allantoin ameliorates amyloid β-peptide-induced memory impairment by regulating the PI3K/Akt/GSK-3β signaling pathway in rats
Tzeng, C., Lee, W.-S., Liu, K., Tsou, H., Chen, C., Peng, W., & Tsai, J.-C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113389 · Cited by 27
Mouse Models of Neurodegenerative Diseases: Criteria and General Methodology
Janus, C., & Welzl, H. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-058-8_19 · Cited by 27
The natural history of consciousness, and the question of whether plants are conscious, in relation to the Hameroff-Penrose quantum-physical ‘Orch OR’ theory of universal consciousness
Barlow, P. W. (2015) · Communicative & Integrative Biology · doi:10.1080/19420889.2015.1041696 · Cited by 30
Early postnatal lead exposure induces tau phosphorylation in the brain of young rats
Rahman, A., Khan, K., Al‐Khaledi, G., Khan, I., & Attur, S. (2012) · Acta Biologica Hungarica · doi:10.1556/abiol.63.2012.4.1 · Cited by 27
TOC1: A valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy
Ward, S. M., Himmelstein, D. S., Ren, Y., Fu, Y., Yu, X., Roberts, K. F., Binder, L. I., & Sahara, N. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.002 · Cited by 28
Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection
Wang, X., Blanchard, J., Grundke, I., Węgiel, J., Deng, H., Siddique, T., & Iqbal, K. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1175-9 · Cited by 28
The role of tau protein in HIV-associated neurocognitive disorders
Brown, L. A. M., Scarola, J., de Smith, A. J., Sanberg, P. R., Tan, J., & Giunta, B. N. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-40 · Cited by 26
Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants
Kimura, T., Hosokawa, T., Taoka, M., Tsutsumi, K., Ando, K., Ishiguro, K., Hosokawa, M., Hasegawa, M., & Hisanaga, S. (2016) · Scientific Reports · doi:10.1038/srep33479 · Cited by 28
Effect Size of Memory Deficits in Mice with Adult-Onset P301L Tau Expression
Hunsberger, H. C., Rudy, C. C., Weitzner, D., Zhang, C., Tosto, D. E., Knowlan, K., Xu, Y., & Reed, M. N. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.057 · Cited by 46
Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles
Penke, B., Tóth, A. M., Földi, I., Szűcs, M., & Janáky, T. (2012) · Electrophoresis · doi:10.1002/elps.201200297 · Cited by 26
Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein
Yin, Z., Valkenburg, F., Hornix, B., Mantingh-Otter, I., Zhou, X., Mari, M. C., Reggiori, F., Dam, D. V., Eggen, B. J. L., Deyn, P. P. D., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161206 · Cited by 26
Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses
Wegmann, S., Bennett, R. E., Amaral, A. C. S., & Hyman, B. T. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.014 · Cited by 29
Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes
Vasilevskaya, A., Taghdiri, F., Burke, C., Tarazi, A., Naeimi, S. A., Khodadadi, M., Goswami, R., Sato, C., Grinberg, M., Moreno, D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102212 · Cited by 27
Some Molecular and Cellular Stress Mechanisms Associated with Neurodegenerative Diseases and Atherosclerosis
Sazonova, M. A., Sinyov, V. V., Ryzhkova, A. I., Sazonova, M. D., Kirichenko, T. V., Khotina, V. A., Khasanova, Z. B., Doroschuk, N. A., Karagodin, V. P., Orekhov, A. N., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020699 · Cited by 27
Dendrimers in the context of targeting central nervous system disorders
Palan, F., & Chatterjee, B. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103474 · Cited by 26
The involvement of glycogen synthase kinase‐3 and protein phosphatase‐2A in lactacystin‐induced tau accumulation
Ren, Q., Liao, X., Wang, X., Qu, Z.-S., & Wang, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.073 · Cited by 26
To be or not to be: the regulation of mRNA fate as a survival strategy during mammalian hibernation
Tessier, S. N., & Storey, K. B. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0512-9 · Cited by 31
Protective Effects of Puerarin against Aβ 1–42-Induced Learning and Memory Impairments in Mice
Wu, L., Tong, T., Wan, S., Yan, T., Ren, F., Bi, K., & Jia, Y. (2016) · Planta Medica · doi:10.1055/s-0042-111521 · Cited by 26
Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology modulates cognitive performance
Tautvydaitė, D., Kukreja, D., Antonietti, J., Henry, H., von Gunten, A., & Popp, J. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0235-0 · Cited by 28
Identification of new BACE1 inhibitors using Pharmacophore and Molecular dynamics simulations approach
Dhanabalan, A. K., Kesherwani, M., Velmurugan, D., & Gunasekaran, K. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.06.001 · Cited by 26
Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways
Hu, J., Yang, Y., Wang, M., Yao, Y., Chang, Y., He, Q., Ma, R., & Li, G. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.020 · Cited by 26
Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease
Reddy, A. P., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.010 · Cited by 25
Challenges and opportunities of diagnostic markers of Alzheimer's disease based on structural magnetic resonance imaging
Hu, X., Meier, M., & Pruessner, J. C. (2023) · Brain and Behavior · doi:10.1002/brb3.2925 · Cited by 24
An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
Sharma, P., & Singh, M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121568 · Cited by 25
The Role of Tissue Non-specific Alkaline Phosphatase (TNAP) in Neurodegenerative Diseases: Alzheimer’s Disease in the Focus
Kellett, K. A. B., & Hooper, N. M. (2015) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-7197-9_17 · Cited by 25
Finding Order within Disorder: Elucidating the Structure of Proteins Associated with Neurodegenerative Disease
Huang, A., & Stultz, C. M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.40 · Cited by 26
Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment
Watamura, N., Toba, J., Yoshii, A., Nikkuni, M., & Ohshima, T. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23674 · Cited by 25
Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
Lai, R. Y. K., Harrington, C. R., & Wischik, C. M. (2016) · Biomolecules · doi:10.3390/biom6020019 · Cited by 24
The Potential of Indole/Indolylquinoline Compounds in Tau Misfolding Reduction by Enhancement of HSPB 1
Chang, K., Lin, C., Chen, H., Huang, H., Chen, S., Lin, T., Ramesh, C., Huang, C., Fung, H., Wu, Y., et al. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12592 · Cited by 25
Ser422 phosphorylation blocks human Tau cleavage by caspase-3: Biochemical implications to Alzheimer’s Disease
Sandhu, P., Naeem, M. M., Lu, C., Kumarathasan, P., Gomes, J., & Basak, A. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.11.087 · Cited by 25
An updated radiosynthesis of [18F]AV1451 for tau PET imaging
Mossine, A. V., Brooks, A. F., Henderson, B. D., Hockley, B. G., Frey, K. A., & Scott, P. J. H. (2017) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-017-0027-7 · Cited by 25
Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease
Zota, I., Chanoumidou, K., Gravanis, A., & Charalampopoulos, I. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1422130 · Cited by 25
Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity
Frenkel‐Pinter, M., Tal, S., Scherzer‐Attali, R., Abu-Hussien, M., Alyagor, I., Eisenbaum, T., Gazit, E., & Segal, D. (2016) · Neurodegenerative Diseases · doi:10.1159/000448518 · Cited by 24
Neuroinflammation and Mitochondrial Dysfunction in the Pathogenesis of Alzheimer?s Disease: Modulation by Coriolus Versicolor (Yun-Zhi) Nutritional Mushroom
Calabrese, V. (2017) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2017/2.942x/2017/1.1088 · Cited by 24
Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings
Delbreil, P., Rabanel, J., Banquy, X., & Brambilla, D. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114397 · Cited by 25
Cyclic dipeptide‐based small molecules modulate zinc‐mediated liquid–liquid phase separation of tau
Ramesh, M., Balachandra, C., Baruah, P., & Govindaraju, T. (2022) · Journal of Peptide Science · doi:10.1002/psc.3465 · Cited by 25
p35/p25 Is Not Essential for Tau and Cytoskeletal Pathology or Neuronal Loss in Niemann–Pick Type C Disease
Hallows, J. L., Iosif, R. E., Biasell, R. D., & Vincent, I. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4834-05.2006 · Cited by 24
The attenuating effects of 1,2,3,4,6 penta-O-galloyl-β-D-glucose on inflammatory cytokines release from activated BV-2 microglial cells
Mendonca, P., Taka, E., Bauer, D. F., Cobourne-Duval, M. K., & Soliman, K. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.01.011 · Cited by 25
Targeting metals rescues the phenotype in an animal model of tauopathy
Sedjahtera, A., Gunawan, L., Bray, L., Hung, L. W., Parsons, J., Okamura, N., Villemagne, V. L., Yanai, K., Liu, X. M., Chan, J., et al. (2018) · Metallomics · doi:10.1039/c8mt00153g · Cited by 24
PKA-CREB Signaling Suppresses Tau Transcription
Liu, H., Jin, X., Yin, X., Jin, N., Liu, F., & Qian, W. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142610 · Cited by 25
Inhibition of proteasome and Shaggy/Glycogen synthase kinase‐3β kinase prevents clearance of phosphorylated tau in Drosophila
Blard, O., Frébourg, T., Campion, D., & Lecourtois, M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21006 · Cited by 24
Altered Function of Hippocampal CA1 Pyramidal Neurons in the rTg4510 Mouse Model of Tauopathy
Dalby, N. O., Volbracht, C., Helboe, L., Larsen, P. H., Jensen, H. S., Egebjerg, J., & Elvang, A. B. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131358 · Cited by 23
Mechanism by Which Aluminum Regulates the Abnormal Phosphorylation of the Tau Protein in Different Cell Lines
Pan, B., Lu, X., Han, X., Huan, J., Gao, D., Cui, S., Ju, X., Zhang, Y., Xu, S., Song, J., et al. (2021) · ACS Omega · doi:10.1021/acsomega.1c04434 · Cited by 23
Prion-like strain effects in tauopathies
Han, Z. Z., Kang, S., Arce, L., & Westaway, D. A. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03620-1 · Cited by 24
Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils
Li, J., Kumar, A., Långström, B., Nordberg, A. K., & Ågren, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00437 · Cited by 25
Cerebrospinal fluid biomarkers of Alzheimer’s disease in cognitively healthy elderly
Glodzik, L. (2013) · Frontiers in bioscience · doi:10.2741/4170 · Cited by 25
Effect of Pin1 or Microtubule Binding on Dephosphorylation of FTDP-17 Mutant Tau
Yotsumoto, K., Saito, T., Asada, A., Oikawa, T., Kimura, T., Uchida, C., Ishiguro, K., Uchida, T., Hasegawa, M., & Hisanaga, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003277 · Cited by 23
NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy
Rossi, F., Geiszler, P. C., Meng, W., Barron, M. R., Prior, M. J. W., Herd-Smith, A., Loreto, A., Lopez, M. Y., Faas, H., Pardon, M., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.11.030 · Cited by 24
Glycogen synthase kinase‐3β (GSK3β) expression in a mouse model of Alzheimer's disease: A light and electron microscopy study
Gandy, J. C., Meléndez‐Ferro, M., Bijur, G. N., LEUVEN, F. V., Roche, J. K., Lechat, B., Devijver, H., Demedts, D., Pérez‐Costas, E., & Roberts, R. C. (2013) · Synapse · doi:10.1002/syn.21642 · Cited by 23
Direct Observation of Aggregation‐Induced Backbone Conformational Changes in Tau Peptides
Jiji, A. C., Shine, A., & Vijayan, V. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606544 · Cited by 22
Sustained Hippocampal Synaptic Pathophysiology Following Single and Repeated Closed-Head Concussive Impacts
McDaid, J., Briggs, C. A., Barrington, N. M., Peterson, D. A., Kozlowski, D. A., & Stutzmann, G. E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652721 · Cited by 22
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
Eddin, A. N., Hamsho, K., Adi, G., Al-Rimawi, M., Alfuwais, M., Rab, S. A., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1210191 · Cited by 26
Role of NMDA receptors in noise-induced tau hyperphosphorylation in rat hippocampus and prefrontal cortex
Li, K., Jia, H.-C., She, X., Cui, B., Zhang, N., Chen, X., Xu, C.-X., An, G., & Ma, Q. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.03.027 · Cited by 22
The aqueous extract of Glycyrrhiza inflata can upregulate unfolded protein response-mediated chaperones to reduce tau misfolding in cell models of Alzheimer’s disease
Lee‐Chen, G., Chang, K.-H., Chen, I., Lin, H.-Y., Chen, H.-C., Lin, C., Lin, T., Weng, Y.-T., Chao, C., Wu, Y.-R., et al. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s96454 · Cited by 22
Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer’s Disease
Beckelman, B. C., Day, S. M., Zhou, X., Donohue, M., Gouras, G. K., Klann, E., Keene, C. D., & Ma, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160036 · Cited by 29
Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration
Dar, K. B., Bhat, A. H., Amin, S., Reshi, B. A., Zargar, M. A., Masood, A., & Ganie, S. A. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00741-0 · Cited by 23
Compartmental protein expression of Tau, GSK-3β and TrkA in cholinergic neurons of aged rats
Niewiadomska, G., Baksalerska-Pazera, M., Lenarcik, I., & Riedel, G. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0488-4 · Cited by 22
Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches
Kelliny, S., Zhou, X., & Bobrovskaya, L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70046 · Cited by 27
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 21
Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
Wang, P., & Ye, Y. (2021) · Life · doi:10.3390/life11090938 · Cited by 21
Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox
Alaouy, M. A. E., Alaqarbeh, M., Ouabane, M., Zaki, H., ElBouhi, M., Badaoui, H., Moukhliss, Y., Sbai, A., Maghat, H., Lakhlifi, T., et al. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2252116 · Cited by 21
Overexpression of Heme Oxygenase 1 Impairs Cognitive Ability and Changes the Plasticity of the Synapse
Li, L., Peng, Y., Hui, Y., Zhang, S., Zhou, Y. L., Li, D., Li, J., Si, Z., Li, J., Wang, D., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150027 · Cited by 22
Posterior cingulate cortex reveals an expression profile of resilience in cognitively intact elders
Kelley, C. M., Ginsberg, S. D., Liang, W. S., Counts, S., & Mufson, E. J. (2022) · Brain Communications · doi:10.1093/braincomms/fcac162 · Cited by 23
New Age of Neuroproteomics in Alzheimer’s Disease Research
Kováčech, B., Žilka, N., & Novák, M. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9358-6 · Cited by 22

Authors: Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., Tanimukai, H., & Grundke-Iqbal, I.
Affiliations: New York State Office for People With Developmental Disabilities (US)
Corresponding author: Iqbal, Khalid
ORCID: Iqbal, Khalid
Chohan, M. Omar
Gong, Cheng-Xin
Khatoon, Sabiha
Liu, Fei
Rahman, Abdur
Tanimukai, Hitoshi
Venue: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher: Elsevier BV
Published: 2005-01
Volume: 1739
Issue: 2-3
Pages: 198-210
ISSN: 0925-4439 (ISSN-L)
DOI: 10.1016/j.bbadis.2004.09.008
OpenAlex: W1998440070
Cited by: 1,037
References: 154
Citations by year: 2026: 28 · 2025: 48 · 2024: 50 · 2023: 67 · 2022: 60 · 2021: 60 · 2020: 57 · 2019: 58 · 2018: 64 · 2017: 48 · 2016: 48 · 2015: 54 · 2014: 52 · 2013: 48 · 2012: 52
FWCI: 3.38
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 3120 d)
Locations: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute on Aging (AG19158, R01AG019158)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: tau protein, tauopathy, Alzheimer's disease, tau hyperphosphorylation, neurofibrillary tangles, paired helical filaments, microtubule stabilization, MAP2, tau kinases, protein phosphatase 2A, frontotemporal dementia, tau conformation, neurodegeneration, tau dephosphorylation, tau-targeted therapy
MeSH terms: Alzheimer Disease, Brain, Enzyme Inhibitors, Humans, Models, Biological, Nerve Degeneration, Neurofibrils, Phosphoprotein Phosphatases, Phosphorylation, Protein Conformation, Protein Kinases, Neurofibrillary Tangles, tau Proteins, Tauopathies, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tau pathology in Alzheimer disease and other tauopathies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks